iSERA Lifesciences Approves Allotment of 1.61 Cr Equity Shares via Share Swap

iSERA Lifesciences Ltd (formerly Covidh Technologies Limited) announced board approval for the allotment of 1,61,82,800 fully paid-up equity shares. These shares, with a face value of ₹10 each, are issued at ₹48.20 per share (including a premium of ₹38.20) on a preferential basis via share swap. The swap ratio is 1:1, meaning one equity share of iSERA Lifesciences for every one equity share of iSERA Biological Limited. This transaction was previously approved by shareholders via postal ballot/e-voting and received in-principle approval from BSE. The allotment is to individuals categorized under Promoter, Promoter Group, and Non-Promoter categories.